Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OpGen : Earnings Flash (OPGN) OPGEN Reports Q1 Revenue $830,000, vs. Street Est of $1.33M

05/13/2021 | 07:34am EDT


© MT Newswires 2021
All news about OPGEN, INC.
07/07OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/07OpGen Announces Partial Adjournment of Annual Meeting
GL
06/30OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AM..
GL
06/28OpGen Group Company Ares Genetics Presents R&D Pipeline Updates
GL
06/25OPGEN, INC.(NASDAQCM : OPGN) dropped from Russell 3000E Growth Index
CI
06/25OPGEN, INC.(NASDAQCM : OPGN) dropped from Russell Microcap Growth Index
CI
06/15OPGEN : Thinking about buying stock in Ocugen, Rapt Therapeutics, ContextLogic, ..
PR
06/09OPGEN : Announces Partial Adjournment of Annual Meeting for Proposal 2 with All ..
PU
06/09OPGEN INC : Submission of Matters to a Vote of Security Holders, Other Events, F..
AQ
06/09OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
GL
More news
Financials (USD)
Sales 2021 7,79 M - -
Net income 2021 -35,6 M - -
Net Debt 2021 3,78 M - -
P/E ratio 2021 -2,33x
Yield 2021 -
Capitalization 87,6 M 87,6 M -
EV / Sales 2021 11,7x
EV / Sales 2022 4,85x
Nbr of Employees 102
Free-Float 99,8%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 2,29 $
Average target price 5,50 $
Spread / Average Target 140%
EPS Revisions
Managers and Directors
Oliver Schacht Chief Executive Officer & Director
Timothy C. Dec CFO, Secretary & Chief Accounting Officer
William E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
G. Terrance Walker Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
OPGEN, INC.12.25%91
MODERNA, INC.209.64%88 312
LONZA GROUP LTD19.02%53 538
IQVIA HOLDINGS INC.36.69%47 022
CELLTRION, INC.-24.93%32 170
SEAGEN INC.-18.16%28 525